Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
Main Author: | Christopher E. Rudd |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.613734/full |
Similar Items
-
Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
by: Carlos Spuch, et al.
Published: (2020-08-01) -
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells
by: Alison Taylor, et al.
Published: (2020-03-01) -
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
by: Christopher E. Rudd, et al.
Published: (2020-06-01) -
Lithium induced neural plasticity
by: Rita Mukhopadhyaya, et al.
Published: (2017-01-01) -
Lithium and Therapeutic Targeting of GSK-3
by: Melinda E. Snitow, et al.
Published: (2021-01-01)